Breaking the Language Barrier: DIRAMS Launches Interpretation Services for Foreigners
The Dongnam Institute of Radiological & Medical Sciences and the Busan Global City Foundation have entered a strategic partnership to provide vital...
Search results for "international patients"
Diagnosing Parkinson’s and Schizophrenia with a Single Drop of Saliva: Breakthrough in South Korean Medical Tech
A South Korean research team has pioneered a technology capable of diagnosing major neurological and psychiatric disorders using only a small sample...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR
Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...
2NE1’s Park Bom Addresses ‘ADD’ Diagnosis in Public Letter to Fans
Park Bom of the group 2NE1 stirred controversy by posting a lengthy letter on the 3rd.
The Power of Perception: Can Your Mindset Make Zero-Calorie Drinks as Satisfying as Sugar?
Among patients with diabetes, many report a genuine preference for zero-calorie beverages over their sugar-laden...
Busan On Hospital to Introduce Proton Therapy: Expanding to Vietnam and Russia
Busan On Hospital has announced a bold new vision on the occasion of its 16th anniversary, aiming to establish a global...
"My Stomach Hurts Like It's Being Squeezed": A Guide to Finding the Right Specialist in Korea
For many foreigners living in Korea, the most stressful question when falling ill isn't "What is wrong with me.
"K-Health Content for 4.7 Billion People": Kormedi.com Launches Global Multilingual Service
Kormedi. com, South Korea’s premier health and medical media outlet, is officially going global.
Simple Strength Routine and Protein Shakes Help Slash Dementia Care Time
A targeted regimen of daily strength exercises and protein supplementation can significantly reduce the physical...
Hanmi’s 'Amoprel' Makes Global Waves: World’s First Ultra-Low Triple Hypertension Drug Lands in JACC
The Phase 3 clinical trial results for Hanmi Pharmaceutical’s Amoprel—the world’s first ultra-low-dose triple...